Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares climbed 25.26% in after-hours trading to $5.30, after the company announced the first patient treatment in its pilot study for recurrent glioblastoma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback